Key figures

  • >€585mGroup sales for full-year 2022
  • >88%Sales % in emerging markets in 2022
  • 2,793Employees (as of end of 2022)
  • Group sales for full-year 2022
  • Sales % in emerging markets in 2022
  • Employees (as of end of 2022)

Growing in selected markets

Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on selected markets in the Middle East, Africa, the CIS Region and Latin America.

Acino is part of ADQ, an Abu Dhabi-based investment and holding company. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets. With a proven track record and in-depth knowledge of our markets, our dedication to get medication to those who need it most, and with a scientific educational approach, we aim to become the preferred brand for patients and professionals. When you choose Acino, you are choosing quality you can rely on.

Acino Commercial Operations

  • Portfolio management
  • Business development and Alliance management
  • Launch management
  • Sales and Marketing excellence
  • Business insights